Clinical trials
Phase 2 Head and Neck Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Jules Bordet Institute | 3 |
| ALX Oncology Inc. | 2 |
| AstraZeneca | 2 |
| Daiichi Sankyo | 2 |
| Kura Oncology, Inc. | 2 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| EMD Serono | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 28 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Melanoma | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Renal Cell | 4 |
| Recurrence | 4 |
| Carcinoma, Squamous Cell | 3 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.